People: Aldeyra Therapeutics Inc (ALDX.A)
12 Jul 2019
Dr. Todd C. Brady is President and Chief Executive Officer Director of Company. From April 2013 to December 2013, Dr. Brady has served as President and Chief Executive Officer since January of 2012 and as a member of our Board of Directors since 2005. Prior to Aldeyra, Dr. Brady served as Entrepreneur in Residence at Domain Associates, LLC, a leading healthcare venture capital firm, where he was a Principal from 2004 to 2013. Dr. Brady currently serves on the Board of Directors of Evoke Pharma, Inc. and Spring Bank Pharmaceuticals, Inc., both of which are publicly traded healthcare companies. Dr. Brady served on the Board of Directors of Oncobiologics, Inc. from 2014 to 2017. Dr. Brady holds a Ph.D. in pathology from Duke University Graduate School, a M.D. from Duke University Medical School, and an A.B. from Dartmouth College in Philosophy and Psychology. Dr. Brady’s extensive knowledge of our business, as well as his years of experience in the biotechnology industry, including executive leadership in several biotechnology companies, contributed to our conclusion that he should serve as a director of our company.
|Total Annual Compensation, USD||473,000|
|Restricted Stock Awards, USD||697,711|
|Long-Term Incentive Plans, USD||239,800|
|All Other, USD||955,632|
|Fiscal Year Total, USD||2,366,140|